RD
RDACU
Rising Dragon Acquisition Corp.
$7.60
0.00%
No data for this timeframe.
Vol
SEC Reports2
Recent Activity
Jun 1, 2026
SEC
Rising Dragon Acquisition Corp. (RDACU) shareholders approved extending the deadline to complete a business combination
8-K — Impact 6/10
May 26, 2026
SEC
Rising Dragon Acquisition Corp. issued two $50,000 unsecured promissory notes to its sponsor (Aurora Beacon LLC) and the
8-K — Impact 4/10
Mar 22, 2026
Event
TOLMETIN SODIUM
Cardiovascular Thrombotic Events Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased ri
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Mar 22, 2026
FDA
TOLMETIN SODIUM
Cardiovascular Thrombotic Events Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, in
Mar 5, 2026
FDA
montelukast sodium
WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS Serious neuropsychiatric (NP) events have been reported with the use of montelukast sodium. The types of even
Mar 5, 2026
FDA
montelukast sodium
WARNING: SERIOUS NEUROPSYCHIATRIC EVENTS Serious neuropsychiatric (NP) events have been reported with the use of montelukast sodium. The types of even
Feb 24, 2026
Clinical Trial
RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
Phase Phase 3 — COMPLETED
Feb 23, 2026
Clinical Trial
Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents
Phase Phase 3 — COMPLETED
Feb 23, 2026
FDA
Amitriptyline Hydrochloride
Suicidality and Antidepressant Drugs : Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in child
Feb 23, 2026
FDA
Amitriptyline Hydrochloride
Suicidality and Antidepressant Drugs : Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in child